$0.9994
At close: Apr 30 EDT
$1.00
0.000600.06%
Pre-Market: 7:48 PM EDT
Comments
Loading...
Esperion Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ESPR | Benzinga
Esperion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 4
EPS
$-0.110
Quarterly Revenue
$69.11M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$332.31M
Analyze the earnings history of Esperion Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics | $0.34 | — | — | — | $137.74M | $53.30M | — | — | 05/06/2025 | Get Alert |
| ESPR | Esperion Therapeutics | -$0.50 | -$0.16 | -$0.11 | 31.25% | $32.25M | $61.58M | $69.11M | 12.23% | 03/04/2025 | Get Alert |
| ESPR | Esperion Therapeutics | -$0.37 | -$0.18 | -$0.15 | 16.67% | $33.97M | $51.32M | $51.63M | 0.61% | 11/07/2024 | Get Alert |
| ESPR | Esperion Therapeutics | -$0.46 | -$0.15 | -$0.05 | 66.67% | $25.79M | $50.59M | $73.83M | 45.95% | 08/12/2024 | Get Alert |
| ESPR | Esperion Therapeutics | -$0.79 | $0.05 | $0.34 | 580.00% | $24.33M | $84.51M | $137.74M | 62.98% | 05/07/2024 | Get Alert |
| ESPR | Esperion Therapeutics | -$0.76 | -$0.48 | -$0.50 | -4.17% | $18.82M | $28.70M | $32.25M | 12.37% | 02/27/2024 | Get Alert |
| ESPR | Esperion Therapeutics | -$0.81 | -$0.43 | -$0.37 | 13.95% | $18.98M | $29.58M | $33.97M | 14.84% | 11/07/2023 | Get Alert |
| ESPR | Esperion Therapeutics | -$1.05 | -$0.63 | -$0.46 | 26.98% | $18.84M | $25.50M | $25.79M | 1.12% | 08/01/2023 | Get Alert |
| ESPR | Esperion Therapeutics | -$0.93 | -$0.65 | -$0.79 | -21.54% | $18.84M | $22.01M | $24.33M | 10.54% | 05/09/2023 | Get Alert |
| ESPR | Esperion Therapeutics | -$1.77 | -$0.84 | -$0.76 | 9.52% | $15.40M | $20.85M | $18.82M | -9.75% | 02/21/2023 | Get Alert |
| ESPR | Esperion Therapeutics | -$2.62 | -$0.93 | -$0.81 | 12.90% | $14.41M | $19.74M | $18.98M | -3.85% | 11/01/2022 | Get Alert |
| ESPR | Esperion Therapeutics | -$1.67 | -$0.93 | -$1.05 | -12.90% | $40.66M | $18.71M | $18.84M | 0.70% | 08/02/2022 | Get Alert |
| ESPR | Esperion Therapeutics | -$3.50 | -$1.04 | -$0.93 | 10.58% | $7.98M | $15.39M | $18.84M | 22.39% | 05/03/2022 | Get Alert |
| ESPR | Esperion Therapeutics | -$3.89 | -$2.27 | -$1.77 | 22.03% | $9.64M | $14.47M | $15.40M | 6.43% | 02/22/2022 | Get Alert |
| ESPR | Esperion Therapeutics | -$3.07 | -$2.79 | -$2.62 | 6.09% | $3.83M | $12.85M | $14.41M | 12.13% | 11/02/2021 | Get Alert |
| ESPR | Esperion Therapeutics | $4.32 | -$1.84 | -$1.67 | 9.24% | $212.24M | $42.27M | $40.66M | -3.81% | 08/03/2021 | Get Alert |
| ESPR | Esperion Therapeutics | -$2.84 | -$2.52 | -$3.50 | -38.89% | $1.84M | $26.12M | $7.98M | -69.46% | 05/04/2021 | Get Alert |
| ESPR | Esperion Therapeutics | -$2.26 | -$3.76 | -$3.89 | -3.46% | $982.00K | $12.52M | $9.64M | -23.02% | 02/23/2021 | Get Alert |
| ESPR | Esperion Therapeutics | -$2.52 | -$3.41 | -$3.07 | 9.97% | $981.00K | $5.93M | $3.83M | -35.36% | 11/02/2020 | Get Alert |
| ESPR | Esperion Therapeutics | -$2.01 | $1.71 | $4.32 | 152.63% | $982.00K | $147.97M | $212.24M | 43.43% | 08/10/2020 | Get Alert |
| ESPR | Esperion Therapeutics | $3.07 | -$3.29 | -$2.84 | 13.68% | $145.42M | $520.00K | $1.84M | 253.85% | 05/06/2020 | Get Alert |
Esperion Therapeutics (ESPR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-04 | $-0.11 | $-0.16 | 31.3 % |
| Q3 | 2024-11-07 | $-0.15 | $-0.18 | 16.7 % |
| Q2 | 2024-08-12 | $-0.05 | $-0.15 | 66.7 % |
| Q1 | 2024-05-07 | $0.34 | $0.05 | 580.0 % |
Esperion Therapeutics (ESPR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-04 | $69.11M | $61.58M | 12.2 % |
| Q3 | 2024-11-07 | $51.63M | $51.32M | 0.61 % |
| Q2 | 2024-08-12 | $73.83M | $50.59M | 46.0 % |
| Q1 | 2024-05-07 | $137.74M | $84.51M | 63.0 % |
FAQ
When is Esperion Therapeutics (NASDAQ:ESPR) reporting earnings?
Esperion Therapeutics (ESPR) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 4, 2025 for Q4.
What were the latest earnings per share (EPS) for Esperion Therapeutics (NASDAQ:ESPR)?
The Actual EPS was $-0.11, which beat the estimate of $-0.16.
What were Esperion Therapeutics’s (NASDAQ:ESPR) revenues?
The Actual Revenue was $69.1M, which beat the estimate of $61.6M.
Browse earnings estimates, EPS, and revenue on all stocks.
